期刊文献+

结直肠癌组织中肿瘤相关巨噬细胞计数与化学趋化因子的相关性 被引量:1

下载PDF
导出
摘要 目的探讨结、直肠癌组织中IL-8、MCP-1、MIP-1a表达特征及与TAM计数的相互关系及临床病理意义。方法采用常规ABC免疫组化法检测56例结、直肠癌组织中TAM计数及IL-8、MCP-1和MIP-1a表达。结果TAM计数高分化组<中分化组<高分化组(P=0.000)。IL-8、MCP-1、MIP-1a评分高分化组、中分化组、低分化组比较差异无统计学意义(P>0.05);IL-8、MCP-1、MIP-1a表达阳性率有转移病例均明显高于未转移病例(P<0.05);化学趋化因子评分值与TAM计数均呈正相关(P<0.01)。结论TAM计数和化学趋化因子与结直肠癌的进展、血管生成、转移发生有密切关系,二者联合检测有助于判断预后。
作者 陈甦
出处 《广西医学》 CAS 2009年第4期526-527,共2页 Guangxi Medical Journal
  • 相关文献

参考文献4

二级参考文献36

  • 1Tian H S,Chin Med J,1984年,97卷,36页
  • 2刘铭球,中华肿瘤杂志,1994年,16卷,269页
  • 3韩铭钧,中华放射学杂志,1988年,22卷,243页
  • 4Ghiara P, Boraschi D, Villa L, Scapigliati G, Taddei C, TagliabueA. In vitro generated mast cells express natural cytotoxicity against tumour cells. Immunology 1985; 55:317-324.
  • 5Henderson WR, Chi EY, Jong EC, Klebanoff SJ. Mast cell-mediated tumor-cell cytotoxicity. Role of the peroxidase system. J Exp Med 1981; 153:520-533.
  • 6Alleva DG, Askew D, Burger CJ, Elgert KD. Fibrosarcoma-induced increase in macrophage tumor necrosis factor α synthesis suppresses T cell responses. J Leukoc Biol 1993; 54:152-160.
  • 7Tani K, Ogushi F, Shimizu T, Sone S. Protease-induced leukocyte chemotaxis and activation: Roles in host defense and inflammation. J Med Invest 2001; 48:133-141.
  • 8Coussens LM, Werb Z. Inflammatory cells and cancer: Think different. J Exp Med 2001; 193:F23-F26.
  • 9Montemurro P, Nishioka H, Dundon WG, de Bernard M, Del Giudice G, Rappuoli R, Montecucco C. The neutrophil-activating protein (HP-NAP) of Helicobacter pylori is a potent stimulant of mast cells. Eur J Immunol 2002; 32:671-676.
  • 10Dimitriadou V, Koutsilieris M. Mast cell-tumor cell interactions:For or against tumour growth and metastasis? Anticancer Res 1997; 17:1541-1549.

共引文献72

同被引文献10

  • 1Leek RD,Lewis CE,Whitehouse R,et al.Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma[J].Cancer Rea,1996,56(20):4 625-4 629.
  • 2Weidner N,Carroll PR,Flax J,et al.Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma[J].Am J Pathol,1993,143(2):401-409.
  • 3Semenza GL.HIF-1:mediator of physiological and pathophysiological responses to hypoxia[J].J Appl Physiol,2000,88(4):1 474-1 480.
  • 4Dai Y,Xu M,Wang Y,et al.HIF-1 alpha induced-VEGF overexpression in bone marrow stem cells protects cardiomyocytes against ischemia[J].Mol Cell Cardiol,2007,42(6):1 036-1 044.
  • 5Burke B,Tang N,Corke KP,et al.Expression of HIF-1 alpha by human macrophages:implications for the use of macrophages in hypoxia-regulated cancer gene therapy[J].Pathol,2002,196(2):204-212.
  • 6Griffiths L,Binley K,Iqball S,et al.The macrophage a novel system to deliver gene therapy to pathological hypoxia[J].Gene Ther,2000,7(3):255-262.
  • 7Espey MG.Tumor macrophage redox and effector mechanisms associated with hypoxia[J].Free Radic Biol Med,2006,41(11):1 621-1 628.
  • 8Berra E,Pages G,Pouyssgur J.MAP kinases and hypoxia in the control of VEGF expression[J].Cancer Metastasis Rev,2000,19(1-2):139-145.
  • 9Li J,Post M,Volk R,et al.PR39,a peptide regulator of angiogenesis[J].Nat Med,2000,6(1):49-55.
  • 10郑青平,倪秉强,伍美娟,罗平,罗展雄,张志红,徐艺安.肝癌放疗前后血浆VEGF表达的临床意义[J].重庆医学,2010,39(3):288-289. 被引量:14

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部